Analyst downgrades typically lead to a negative short-term reaction in the stock price, especially with a significant reduction in the price target. This downgrade from Buy to Hold, coupled with a substantial decrease in the price target from $15 to $6, suggests a bearish outlook on TMCI's future performance, likely impacting investor sentiment and potentially leading to a decrease in stock price in the short term.